Share Price and Basic Stock Data
Last Updated: January 23, 2026, 10:07 pm
| PEG Ratio | 248.99 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Croissance Ltd operates in the construction, contracting, and engineering industry, with its stock currently priced at ₹3.40 and a market capitalization of ₹23.3 Cr. The company’s revenue has experienced significant volatility in recent quarters. For example, sales reported in December 2022 stood at ₹0.69 Cr, peaking at ₹1.77 Cr in March 2023, before declining sharply to ₹0.16 Cr by September 2023. The most recent quarter, December 2023, saw sales drop to ₹0.06 Cr, indicating a downward trend that may raise concerns about operational stability. Over the years, annual sales figures have been inconsistent, with the highest recorded at ₹2.60 Cr in March 2023, followed by a stark decline to ₹0.66 Cr in March 2024 and further down to ₹0.10 Cr in March 2025. This erratic performance raises questions about the company’s ability to maintain sustainable growth in a competitive sector.
Profitability and Efficiency Metrics
Profitability metrics for Croissance Ltd reveal a challenging landscape. The company reported a net profit of ₹0.18 Cr, translating to a P/E ratio of 49.6, which is relatively high compared to industry averages. Operating profit margins fluctuated significantly, with a peak of 50% in September 2023 but a subsequent decline, as seen in March 2025 where OPM stood at -50%. The interest coverage ratio, at 6.61x, indicates that the company can comfortably meet its interest obligations, although it has recorded no borrowings. Efficiency metrics such as return on capital employed (ROCE) and return on equity (ROE) are notably low, with ROCE at 0.13% and ROE at 0.00%. This lack of profitability and efficiency may hinder the company’s ability to attract new investments and sustain operational effectiveness.
Balance Sheet Strength and Financial Ratios
The balance sheet of Croissance Ltd reflects a cautious financial position. The company reported reserves of ₹1.02 Cr with no borrowings, indicating a debt-free status which typically strengthens financial health. However, the working capital days have dramatically worsened, recorded at -6,241.50 days in March 2025, highlighting potential liquidity issues. The current ratio is at 0.76, below the ideal threshold of 1, suggesting that current liabilities exceed current assets. Additionally, the enterprise value stood at ₹16.79 Cr, with an EV/EBITDA ratio of 1411.06, indicating overvaluation relative to earnings. The price-to-book value ratio is at 2.14x, which is high compared to sector norms, further suggesting that the market may have priced in future growth that has yet to materialize.
Shareholding Pattern and Investor Confidence
Croissance Ltd’s shareholding pattern indicates a strong promoter presence, holding 59.79% of shares, while the public holds 40.22%. The number of shareholders increased significantly to 12,489 by September 2025, suggesting growing interest in the company despite its financial inconsistencies. This promoter confidence can be seen as a positive signal for potential investors. However, the absence of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) may reflect a lack of institutional confidence in the company’s prospects. The sustained promoter holding coupled with a high public shareholding might help stabilize the stock in uncertain market conditions, but the lack of institutional backing could inhibit larger capital inflows necessary for expansion and growth.
Outlook, Risks, and Final Insight
The outlook for Croissance Ltd remains uncertain, with several risks and opportunities ahead. The company’s ability to stabilize its revenue and improve profitability will be crucial for future growth. The significant drop in sales and fluctuating profit margins indicate operational challenges that need addressing. On the positive side, being debt-free provides a solid foundation for potential growth without the burden of interest payments. However, the extreme negative working capital days could pose liquidity challenges. If the company can streamline operations and enhance revenue generation, it may leverage its strong promoter backing to attract more investors. Conversely, continued financial instability may deter potential shareholders, leading to further declines in stock performance. Overall, stakeholders should monitor performance closely to gauge the company’s recovery trajectory in the construction sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Engineering and Projects Ltd | 46.0 Cr. | 29.8 | 49.9/22.5 | 4.38 | 39.4 | 0.00 % | 20.5 % | 25.9 % | 10.0 |
| Modis Navnirman Ltd | 607 Cr. | 310 | 409/220 | 74.0 | 46.5 | 0.00 % | 12.9 % | 9.88 % | 10.0 |
| Modulex Construction Technologies Ltd | 138 Cr. | 19.9 | 33.2/18.0 | 44.7 | 0.00 % | 2.51 % | 1.54 % | 10.0 | |
| MPDL Ltd | 25.7 Cr. | 34.7 | 62.0/34.2 | 127 | 0.00 % | 2.87 % | 4.16 % | 10.0 | |
| IITL Projects Ltd | 29.4 Cr. | 59.0 | 77.9/44.6 | 2.12 | 0.00 % | 16.6 % | % | 10.0 | |
| Industry Average | 16,339.10 Cr | 216.66 | 69.34 | 134.53 | 0.18% | 16.34% | 21.32% | 21.29 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.69 | 1.77 | 0.40 | 0.16 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.56 | 1.29 | 0.41 | 0.08 | 0.03 | 0.06 | 0.09 | 0.29 | 0.20 | -0.43 | 0.12 | 0.18 | 0.18 |
| Operating Profit | 0.13 | 0.48 | -0.01 | 0.08 | 0.03 | -0.06 | -0.09 | -0.29 | -0.20 | 0.43 | -0.12 | -0.18 | -0.18 |
| OPM % | 18.84% | 27.12% | -2.50% | 50.00% | 50.00% | ||||||||
| Other Income | 0.03 | 0.03 | 0.04 | 0.00 | 0.00 | 0.01 | 0.10 | 0.13 | -0.07 | 0.00 | 0.13 | 0.20 | 0.20 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.16 | 0.51 | 0.03 | 0.08 | 0.03 | -0.05 | 0.01 | -0.16 | -0.27 | 0.43 | 0.01 | 0.02 | 0.02 |
| Tax % | 0.00% | 43.14% | 33.33% | 0.00% | 0.00% | 40.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | 0.16 | 0.29 | 0.02 | 0.08 | 0.03 | -0.07 | 0.01 | -0.16 | -0.27 | 0.42 | 0.01 | 0.02 | 0.02 |
| EPS in Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 | -0.00 | -0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
Last Updated: January 8, 2026, 10:02 pm
Below is a detailed analysis of the quarterly data for Croissance Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.00 Cr..
- For Expenses, as of Dec 2025, the value is 0.18 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.18 Cr..
- For Operating Profit, as of Dec 2025, the value is -0.18 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded -0.18 Cr..
- For OPM %, as of Dec 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.00%.
- For Other Income, as of Dec 2025, the value is 0.20 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.20 Cr..
- For Interest, as of Dec 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.00 Cr..
- For Depreciation, as of Dec 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Dec 2025, the value is 0.02 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.02 Cr..
- For Tax %, as of Dec 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.00%.
- For Net Profit, as of Dec 2025, the value is 0.02 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.02 Cr..
- For EPS in Rs, as of Dec 2025, the value is 0.00. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.00.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:54 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.61 | 0.28 | 0.24 | 0.20 | 0.14 | 0.40 | 0.21 | 0.06 | 0.20 | 2.60 | 0.66 | 0.10 | 0.00 |
| Expenses | 2.52 | 0.19 | 0.18 | 0.15 | 0.13 | 0.31 | 0.16 | 0.03 | 0.15 | 2.01 | 0.58 | 0.15 | 0.07 |
| Operating Profit | 0.09 | 0.09 | 0.06 | 0.05 | 0.01 | 0.09 | 0.05 | 0.03 | 0.05 | 0.59 | 0.08 | -0.05 | -0.07 |
| OPM % | 3.45% | 32.14% | 25.00% | 25.00% | 7.14% | 22.50% | 23.81% | 50.00% | 25.00% | 22.69% | 12.12% | -50.00% | |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 | 0.12 | 0.01 | 0.06 | 0.26 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.09 | 0.09 | 0.06 | 0.05 | 0.01 | 0.09 | 0.05 | 0.03 | 0.19 | 0.71 | 0.09 | 0.01 | 0.19 |
| Tax % | 33.33% | 33.33% | 50.00% | 40.00% | 0.00% | 22.22% | 20.00% | 33.33% | 31.58% | 30.99% | 22.22% | 100.00% | |
| Net Profit | 0.06 | 0.06 | 0.04 | 0.03 | 0.01 | 0.06 | 0.03 | 0.02 | 0.13 | 0.49 | 0.07 | 0.00 | 0.18 |
| EPS in Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | -33.33% | -25.00% | -66.67% | 500.00% | -50.00% | -33.33% | 550.00% | 276.92% | -85.71% | -100.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -33.33% | 8.33% | -41.67% | 566.67% | -550.00% | 16.67% | 583.33% | -273.08% | -362.64% | -14.29% |
Croissance Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -10% |
| 5 Years: | -14% |
| 3 Years: | -21% |
| TTM: | -100% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -100% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -19% |
| 5 Years: | -10% |
| 3 Years: | -26% |
| 1 Year: | -38% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 2% |
| 3 Years: | 2% |
| Last Year: | 0% |
Last Updated: September 5, 2025, 3:06 pm
Balance Sheet
Last Updated: December 4, 2025, 2:41 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.85 | 6.85 | 6.85 | 6.85 | 6.85 | 6.85 | 6.85 | 6.85 | 6.85 | 6.85 | 6.85 | 6.85 | 6.85 |
| Reserves | -6.22 | 0.09 | 0.13 | 0.16 | 0.17 | 0.24 | 0.27 | 0.29 | 0.43 | 0.92 | 1.00 | 0.99 | 1.02 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.41 | 0.49 | 0.49 | 0.04 | 0.00 | 0.00 |
| Other Liabilities | 0.09 | 0.13 | 0.15 | 0.17 | 0.20 | 0.22 | 0.40 | 0.40 | 0.45 | 2.36 | 1.36 | 7.36 | 7.37 |
| Total Liabilities | 0.72 | 7.07 | 7.13 | 7.18 | 7.22 | 7.31 | 7.52 | 7.95 | 8.22 | 10.62 | 9.25 | 15.20 | 15.24 |
| Fixed Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 0.72 | 7.07 | 7.13 | 7.18 | 7.22 | 7.31 | 7.52 | 7.95 | 8.22 | 10.62 | 9.25 | 15.20 | 15.24 |
| Total Assets | 0.72 | 7.07 | 7.13 | 7.18 | 7.22 | 7.31 | 7.52 | 7.95 | 8.22 | 10.62 | 9.25 | 15.20 | 15.24 |
Below is a detailed analysis of the balance sheet data for Croissance Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 6.85 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.85 Cr..
- For Reserves, as of Sep 2025, the value is 1.02 Cr.. The value appears strong and on an upward trend. It has increased from 0.99 Cr. (Mar 2025) to 1.02 Cr., marking an increase of 0.03 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 7.37 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.36 Cr. (Mar 2025) to 7.37 Cr., marking an increase of 0.01 Cr..
- For Total Liabilities, as of Sep 2025, the value is 15.24 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 15.20 Cr. (Mar 2025) to 15.24 Cr., marking an increase of 0.04 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 15.24 Cr.. The value appears strong and on an upward trend. It has increased from 15.20 Cr. (Mar 2025) to 15.24 Cr., marking an increase of 0.04 Cr..
- For Total Assets, as of Sep 2025, the value is 15.24 Cr.. The value appears strong and on an upward trend. It has increased from 15.20 Cr. (Mar 2025) to 15.24 Cr., marking an increase of 0.04 Cr..
Notably, the Reserves (1.02 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.09 | 0.09 | 0.06 | 0.05 | 0.01 | 0.09 | 0.05 | -0.38 | -0.44 | 0.10 | 0.04 | -0.05 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 92.30 | 990.71 | 1,262.29 | 1,587.75 | 2,372.50 | 921.62 | 1,998.81 | 8,881.67 | 1,679.00 | 473.10 | 2,107.05 | 13,906.50 |
| Inventory Days | 0.00 | 0.00 | 0.00 | |||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 92.30 | 990.71 | 1,262.29 | 1,587.75 | 2,372.50 | 921.62 | 1,998.81 | 8,881.67 | 1,679.00 | 473.10 | 2,107.05 | 13,906.50 |
| Working Capital Days | 86.70 | 899.46 | 1,110.21 | 1,405.25 | 2,007.50 | 775.62 | 1,425.24 | 6,935.00 | 967.25 | 150.21 | 27.65 | -6,241.50 |
| ROCE % | 14.88% | 2.38% | 0.86% | 0.71% | 0.14% | 1.28% | 0.70% | 0.41% | 2.48% | 8.86% | 1.11% | 0.13% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 0.00 | 0.01 | 0.07 | 0.02 | 0.00 |
| Diluted EPS (Rs.) | 0.00 | 0.01 | 0.07 | 0.02 | 0.00 |
| Cash EPS (Rs.) | 0.00 | 0.01 | 0.07 | 0.01 | 0.00 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1.14 | 1.15 | 1.13 | 1.06 | 1.04 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1.14 | 1.15 | 1.13 | 1.06 | 1.04 |
| Revenue From Operations / Share (Rs.) | 0.01 | 0.09 | 0.37 | 0.02 | 0.01 |
| PBDIT / Share (Rs.) | 0.00 | 0.01 | 0.10 | 0.02 | 0.00 |
| PBIT / Share (Rs.) | 0.00 | 0.01 | 0.10 | 0.02 | 0.00 |
| PBT / Share (Rs.) | 0.00 | 0.01 | 0.10 | 0.02 | 0.00 |
| Net Profit / Share (Rs.) | 0.00 | 0.01 | 0.07 | 0.01 | 0.00 |
| NP After MI And SOA / Share (Rs.) | 0.00 | 0.01 | 0.07 | 0.01 | 0.00 |
| PBDIT Margin (%) | 11.36 | 13.93 | 27.32 | 97.58 | 53.63 |
| PBIT Margin (%) | 11.36 | 13.93 | 27.32 | 97.58 | 53.63 |
| PBT Margin (%) | 9.64 | 13.93 | 27.32 | 96.38 | 53.29 |
| Net Profit Margin (%) | 2.96 | 10.31 | 18.79 | 66.28 | 39.44 |
| NP After MI And SOA Margin (%) | 2.96 | 10.31 | 18.79 | 66.28 | 39.44 |
| Return on Networth / Equity (%) | 0.03 | 0.87 | 6.29 | 1.81 | 0.31 |
| Return on Capital Employeed (%) | 0.15 | 1.17 | 8.60 | 2.49 | 0.40 |
| Return On Assets (%) | 0.02 | 0.73 | 4.60 | 1.60 | 0.28 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.06 | 0.06 | 0.05 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.06 | 0.06 | 0.05 |
| Asset Turnover Ratio (%) | 0.01 | 0.06 | 0.27 | 0.02 | 0.00 |
| Current Ratio (X) | 0.76 | 1.50 | 1.45 | 2.17 | 3.87 |
| Quick Ratio (X) | 0.76 | 1.50 | 1.45 | 2.17 | 3.87 |
| Interest Coverage Ratio (X) | 6.61 | 0.00 | 0.00 | 80.92 | 159.13 |
| Interest Coverage Ratio (Post Tax) (X) | 2.72 | 0.00 | 0.00 | 55.96 | 118.02 |
| Enterprise Value (Cr.) | 16.79 | 22.78 | 49.91 | 58.69 | 22.69 |
| EV / Net Operating Revenue (X) | 160.38 | 34.35 | 19.17 | 294.91 | 394.58 |
| EV / EBITDA (X) | 1411.06 | 246.49 | 70.16 | 302.20 | 735.67 |
| MarketCap / Net Operating Revenue (X) | 160.40 | 35.26 | 18.98 | 292.45 | 387.45 |
| Price / BV (X) | 2.14 | 2.98 | 6.36 | 7.99 | 3.12 |
| Price / Net Operating Revenue (X) | 161.18 | 35.26 | 18.99 | 292.76 | 391.57 |
| EarningsYield | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
After reviewing the key financial ratios for Croissance Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 3. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.14. It has decreased from 1.15 (Mar 24) to 1.14, marking a decrease of 0.01.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.14. It has decreased from 1.15 (Mar 24) to 1.14, marking a decrease of 0.01.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.01. It has decreased from 0.09 (Mar 24) to 0.01, marking a decrease of 0.08.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For PBDIT Margin (%), as of Mar 25, the value is 11.36. This value is within the healthy range. It has decreased from 13.93 (Mar 24) to 11.36, marking a decrease of 2.57.
- For PBIT Margin (%), as of Mar 25, the value is 11.36. This value is within the healthy range. It has decreased from 13.93 (Mar 24) to 11.36, marking a decrease of 2.57.
- For PBT Margin (%), as of Mar 25, the value is 9.64. This value is below the healthy minimum of 10. It has decreased from 13.93 (Mar 24) to 9.64, marking a decrease of 4.29.
- For Net Profit Margin (%), as of Mar 25, the value is 2.96. This value is below the healthy minimum of 5. It has decreased from 10.31 (Mar 24) to 2.96, marking a decrease of 7.35.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.96. This value is below the healthy minimum of 8. It has decreased from 10.31 (Mar 24) to 2.96, marking a decrease of 7.35.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 15. It has decreased from 0.87 (Mar 24) to 0.03, marking a decrease of 0.84.
- For Return on Capital Employeed (%), as of Mar 25, the value is 0.15. This value is below the healthy minimum of 10. It has decreased from 1.17 (Mar 24) to 0.15, marking a decrease of 1.02.
- For Return On Assets (%), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.73 (Mar 24) to 0.02, marking a decrease of 0.71.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.01. It has decreased from 0.06 (Mar 24) to 0.01, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 0.76. This value is below the healthy minimum of 1.5. It has decreased from 1.50 (Mar 24) to 0.76, marking a decrease of 0.74.
- For Quick Ratio (X), as of Mar 25, the value is 0.76. This value is below the healthy minimum of 1. It has decreased from 1.50 (Mar 24) to 0.76, marking a decrease of 0.74.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.61. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 6.61, marking an increase of 6.61.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.72. This value is below the healthy minimum of 3. It has increased from 0.00 (Mar 24) to 2.72, marking an increase of 2.72.
- For Enterprise Value (Cr.), as of Mar 25, the value is 16.79. It has decreased from 22.78 (Mar 24) to 16.79, marking a decrease of 5.99.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 160.38. This value exceeds the healthy maximum of 3. It has increased from 34.35 (Mar 24) to 160.38, marking an increase of 126.03.
- For EV / EBITDA (X), as of Mar 25, the value is 1,411.06. This value exceeds the healthy maximum of 15. It has increased from 246.49 (Mar 24) to 1,411.06, marking an increase of 1,164.57.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 160.40. This value exceeds the healthy maximum of 3. It has increased from 35.26 (Mar 24) to 160.40, marking an increase of 125.14.
- For Price / BV (X), as of Mar 25, the value is 2.14. This value is within the healthy range. It has decreased from 2.98 (Mar 24) to 2.14, marking a decrease of 0.84.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 161.18. This value exceeds the healthy maximum of 3. It has increased from 35.26 (Mar 24) to 161.18, marking an increase of 125.92.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.00.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Croissance Ltd:
- Net Profit Margin: 2.96%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.15% (Industry Average ROCE: 16.34%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.03% (Industry Average ROE: 21.32%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.72
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.76
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 49.6 (Industry average Stock P/E: 69.34)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.96%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Construction, Contracting & Engineering | 306, 1st Floor, 17th Cross, Bengaluru Karnataka 560032 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sravan Prabhakar Veledandi | Managing Director |
| Mr. Amaresh Rao Gaikwad | Whole Time Director |
| Mr. Hriday Bahri | Non Executive Director |
| Mr. Hemant Bahri | Director |
| Ms. Sowmya Ranganath | Independent Director |
| Ms. Shivani Marda | Addnl.Independent Director |
FAQ
What is the intrinsic value of Croissance Ltd?
Croissance Ltd's intrinsic value (as of 26 January 2026) is ₹0.67 which is 80.29% lower the current market price of ₹3.40, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹23.3 Cr. market cap, FY2025-2026 high/low of ₹4.32/2.21, reserves of ₹1.02 Cr, and liabilities of ₹15.24 Cr.
What is the Market Cap of Croissance Ltd?
The Market Cap of Croissance Ltd is 23.3 Cr..
What is the current Stock Price of Croissance Ltd as on 26 January 2026?
The current stock price of Croissance Ltd as on 26 January 2026 is ₹3.40.
What is the High / Low of Croissance Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Croissance Ltd stocks is ₹4.32/2.21.
What is the Stock P/E of Croissance Ltd?
The Stock P/E of Croissance Ltd is 49.6.
What is the Book Value of Croissance Ltd?
The Book Value of Croissance Ltd is 0.11.
What is the Dividend Yield of Croissance Ltd?
The Dividend Yield of Croissance Ltd is 0.00 %.
What is the ROCE of Croissance Ltd?
The ROCE of Croissance Ltd is 0.13 %.
What is the ROE of Croissance Ltd?
The ROE of Croissance Ltd is 0.00 %.
What is the Face Value of Croissance Ltd?
The Face Value of Croissance Ltd is 1.00.